Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:453-460
Published online before print January 15, 2007, doi: 10.1161/01.HYP.0000256957.10242.75
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/3/453    most recent
01.HYP.0000256957.10242.75v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bella, J. N.
Right arrow Articles by Arnett, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bella, J. N.
Right arrow Articles by Arnett, D. K.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Valve Diseases
*High Blood Pressure
Related Collections
Right arrow Valvular heart disease
Right arrow Echocardiography
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease

(Hypertension. 2007;49:453.)
© 2007 American Heart Association, Inc.


Original Articles

Genome-Wide Linkage Mapping for Valve Calcification Susceptibility Loci in Hypertensive Sibships

The Hypertension Genetic Epidemiology Network Study

Jonathan N. Bella; Weihong Tang; Aldi Kraja; Dabeeru C. Rao; Steven C. Hunt; Michael B. Miller; Vittorio Palmieri; Mary J. Roman; Dalane W. Kitzman; Albert Oberman; Richard B. Devereux; Donna K. Arnett

From the Weill Medical College (J.N.B., V.P., M.J.R., R.B.D.), Cornell University, New York, NY; the Bronx-Lebanon Hospital Center (J.N.B.), Bronx, NY; the University of Minnesota (W.T., M.B.M.), Minneapolis; Washington University (A.K., D.C.R.), St Louis, Mo; the School of Medicine (S.C.H.), University of Utah, Salt Lake City; the School of Medicine (D.W.K.), Wake Forrest University, Winston-Salem, NC; and the University of Alabama at Birmingham (A.O., D.K.A.).

Correspondence to Jonathan N. Bella, Bronx-Lebanon Hospital Center, Division of Cardiology (12th Floor), 1650 Grand Concourse, Bronx, NY 10457. E-mail jonnbella{at}earthlink.net

It remains unclear whether genetic factors contribute to the susceptibility to valve calcification. Accordingly, echocardiograms and genotyping were performed in 1871 hypertensive siblings who participated in the Hypertension Genetic Epidemiology Network Study. Genome-wide affected sibpair nonparametric linkage analysis was conducted using the allele-sharing method implemented in the Merlin computer program. A total of 1014 sibships from 858 families were evaluated for aortic valve sclerosis or mitral annular calcification. Of these, 78 sibships from 68 families contained ≥2 affected siblings with ≥1 type of valve calcification (142 affected siblings). All 3 of the traits showed a modest degree of familial aggregation, with sibling recurrence risk (SD) and sibling recurrence risk ratio (95% CI) being 0.25 (0.035) and 2.31 (1.72 to 3.11) for aortic valve sclerosis, 0.25 (0.035) and 1.78 (1.36 to 2.33) for mitral annular calcification, and 0.31 (0.030) and 1.52 (1.24 to 1.85) for aortic valve sclerosis and mitral annular calcification, respectively. Affected sibpair linkage analysis revealed the highest logarithm of odds score (3.14) in chromosome 16 at 105.6 cM for aortic valve sclerosis. Other chromosomal regions with logarithm of odds score ≥1.9 were found in chromosomes 19 (2.88), 16 (2.63), 1 (2.12), and 2 (2.03) for aortic valve sclerosis and chromosome 13 (2.12) for any valve calcification. There was no logarithm of odds score ≥1.9 for mitral annular calcification. Our study shows strong linkage of aortic valve sclerosis to chromosome 16q22.1-q22.3 and suggestive linkage to chromosome 19p13.11-p11 and identifies several other promising genomic regions that may contain specific susceptibility loci for valve calcification.


Key Words: genetics • valves • calcification • echocardiography • epidemiology




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
T. V. Tkatchenko, R. A. Moreno-Rodriguez, S. J. Conway, J. D. Molkentin, R. R. Markwald, and A. V. Tkatchenko
Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease
Physiol Genomics, November 1, 2009; 39(3): 160 - 168.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. N. Bella
Genomics of Aortic Valve Disease
J. Am. Coll. Cardiol., August 5, 2008; 52(6): 498 - 498.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Bosse, P. Mathieu, and P. Pibarot
Reply
J. Am. Coll. Cardiol., August 5, 2008; 52(6): 498 - 499.
[Full Text] [PDF]